{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:13:25Z","timestamp":1793391205760,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.recot.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:01:33Z","timestamp":1738342893000},"page":"T210-T220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Rivaroxaban versus enoxaparin for thromboprophylaxis in orthopedic surgery: A meta-analysis"],"prefix":"10.1016","volume":"69","author":[{"given":"O.","family":"Abad V\u00e9laz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Carbonel Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.recot.2025.01.005_bib0145","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.recot.2025.01.005_bib0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.recot.2025.01.005_bib0155","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.jvs.2009.01.058","article-title":"Call to action to prevent venous thromboembolism","volume":"49","author":"Wakefield","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.recot.2025.01.005_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/02813430310003543","article-title":"Deep venous thrombosis: a new task for primary health care. A randomised economic study of outpatient and inpatient treatment","volume":"22","author":"Backman","year":"2004","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.recot.2025.01.005_bib0165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1378\/chest.11-2404","article-title":"American College of Chest Physicians: prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.recot.2025.01.005_bib0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.recot.2025.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/0003088-200948010-00001","article-title":"Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development","volume":"48","author":"Eriksson","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.recot.2025.01.005_bib0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.08-0673","article-title":"New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Weitz","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.recot.2025.01.005_bib0185","series-title":"Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism","year":"2018"},{"key":"10.1016\/j.recot.2025.01.005_bib0190","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH12-12-0919","article-title":"Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France Italy and Spain","volume":"110","author":"Monreal","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.recot.2025.01.005_bib0195","first-page":"53","article-title":"Adherencia y satisfacci\u00f3n en la profilaxis antitromb\u00f3tica ambulatoria oral frente a la parenteral: estudio SALTO","volume":"57","author":"Peidro","year":"2013","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"10.1016\/j.recot.2025.01.005_bib0200","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.recot.2025.01.005_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.recot.2025.01.005_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3120","article-title":"Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses","volume":"3","author":"Moher","year":"1999","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.recot.2025.01.005_bib0215","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.thromres.2015.10.009","article-title":"Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: systemic review, traditional meta-analysis, dose\u2013response meta-analysis and network meta-analysis","volume":"136","author":"Feng","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.recot.2025.01.005_bib0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.recot.2025.01.005_bib0225","series-title":"Science editors\u2019 handbook","article-title":"Basic statistical reporting for articles published in biomedical journals: the \u201cStatistical Analyses and Methods in the Published Literature\u201d or \u201cThe SAMPL Guidelines\u201d","author":"Lang","year":"2013"},{"key":"10.1016\/j.recot.2025.01.005_bib0230","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.recot.2025.01.005_bib0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1160\/th15-07-0527","article-title":"Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty","volume":"115","author":"Kim","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.recot.2025.01.005_bib0240","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/CIRCULATIONAHA.106.642074","article-title":"A once-daily, oral, direct factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement","volume":"114","author":"Eriksson","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.recot.2025.01.005_bib0245","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.recot.2025.01.005_bib0250","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.recot.2025.01.005_bib0255","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial","volume":"373","author":"Turpie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.recot.2025.01.005_bib0260","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1913808","article-title":"Rivaroxaban or enoxaparin in nonmajor orthopedic surgery","volume":"382","author":"Samama","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.recot.2025.01.005_bib0265","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.arth.2016.09.033","article-title":"Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: a meta-analysis","volume":"32","author":"Venker","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.recot.2025.01.005_bib0270","doi-asserted-by":"crossref","first-page":"e14539","DOI":"10.1097\/MD.0000000000014539","article-title":"Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: a systematic review and meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.recot.2025.01.005_bib0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1160\/TH12-07-0510","article-title":"Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery. Findings from the ORTHO-TEP registry","volume":"109","author":"Beyer-Westendorf","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.recot.2025.01.005_bib0280","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1076029615607303","article-title":"Rivaroxaban for thromboprophylaxis after fracture-related orthopedic surgery in routine clinical practice","author":"Lassen","year":"2016","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888441525000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888441525000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:49:07Z","timestamp":1741114147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888441525000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1888441525000177"],"URL":"https:\/\/doi.org\/10.1016\/j.recot.2025.01.005","relation":{},"ISSN":["1888-4415"],"issn-type":[{"value":"1888-4415","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Rivaroxaban versus enoxaparin for thromboprophylaxis in orthopedic surgery: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cirug\u00eda Ortop\u00e9dica y Traumatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.recot.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recot.2023.09.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SECOT. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}